Aptevo Therapeutics (APVO) Return on Equity [ROE] (2016 - 2026)
Aptevo Therapeutics (APVO) posted Return on Equity [ROE] of -302.03% for Q2 2026, up 649.26 percentage points from -951.30% a year earlier but down 119.18 percentage points from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025, Aptevo Therapeutics' Return on Equity [ROE] came in at -234.61%, up 49.67 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -109.77 percentage points (FY2020 to FY2025).
- In prior years, Aptevo Therapeutics' Return on Equity [ROE] was -284.28% in FY2024 (-168.96 pp), -115.32% in FY2023 (-198.98 pp), 83.66% in FY2022 (+403.22 pp) and -319.56% in FY2021 (-194.72 pp).
- Quarterly Return on Equity [ROE] has run from a low of -1444.49% in Q1 2025 to a high of 89.73% in Q1 2023 over five years.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last four quarters, with an average year-over-year change of +17.91 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2026, with a gain of 1261.63 percentage points; the weakest was Q1 2025, with a drop of 1149.58 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -182.85% (Q1 2026), -150.80% (Q4 2025) and -221.89% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Aptevo Therapeutics | 2.58 Mn | -64.42 Mn | - | -302.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -302.03% |
| Mar 31, 2026 | -182.85% |
| Dec 31, 2025 | -150.80% |
| Sep 30, 2025 | -221.89% |
| Jun 30, 2025 | -951.30% |
| Mar 31, 2025 | -1,444.49% |
| Dec 31, 2024 | -525.99% |
| Sep 30, 2024 | -534.08% |
| Jun 30, 2024 | -472.35% |
| Mar 31, 2024 | -294.90% |
| Dec 31, 2023 | -129.27% |
| Sep 30, 2023 | -104.30% |
| Jun 30, 2023 | -88.39% |
| Mar 31, 2023 | 89.73% |
| Dec 31, 2022 | 47.59% |
| Sep 30, 2022 | 32.97% |
| Jun 30, 2022 | 82.08% |
| Dec 31, 2021 | -668.95% |
| Sep 30, 2021 | -276.18% |
| Jun 30, 2021 | -238.11% |
API Access
Aptevo Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();